Multi-agent conviction signals powered by SEC filings, insider trades, institutional holdings, and earnings data.
GS [bearish, low confidence]: GS shows strong YoY net income growth (18.8% to $5.6B) and 4/4 EPS beats, but QoQ net income collapsed 67.2% while operating cash flow remains deeply negative (-$31.9B, +29.4% QoQ). Analysts price in 13.2% downside despite 4Q earnings consistency. CEO sold $2.15M of shares in a single transaction with no insider buys in 90 days, signaling negative sentiment despite exercise of 34,017 shares by CEO (not sales). Regulatory capital rules (March 27) will directly increase capital surcharges for GS as a G-SIB, reducing leverage and ROE. Fiduciary duty guidance (March 31) may constrain asset management fees. Whistleblower protections (April 1) raise compliance costs by 1.5-2% of pre-tax income. Institutions added 725+249+157=1,131 shares of GS in Q1 2026, but total value remains $0M with 0.0% ownership changes. The positions are de minimis ($0M) and lack conviction. All moves are [NEW] but lack dollar value reporting.
1m
+1
3m
-18
6m
-21
See exactly what each AI agent found — forensic accounting flags, insider clusters, institutional shifts, and more.
The system did not produce a valid trade setup for this signal.
Our AI analyst team runs 5 specialized agents on every stock. Unlock detailed breakdowns, trade plans, and real-time alerts.
Not financial advice. For informational purposes only. Past performance does not guarantee future results.